COVID-19

News

Convalescent plasma misses the mark in phase 2 trial

Hopes that antibody-laden plasma taken from recovered COVID-19 patients could lessen the severity of the disease in others have taken a knock.

News

Coronavirus vaccine: how pharma is picking up the pace

AZ, J&J COVID-19 vaccine trials okay to restart in US

US trials of AstraZeneca’s experimental COVID-19 vaccine AZD1222 have been cleared to restart by the FDA, several weeks after testing was suspended following a serious adve

News

Moderna nears COVID-19 vaccine finish line as it wraps up st...

Moderna is close to completing its phase 3 trial of COVID-19 vaccine candidate mRNA-1273 after completing recruitment of the 30,000 subjects in the trial.

News

Gilead’s remdesivir finally gets US approval

Gilead’s Veklury (remdesivir) has become the first COVID-19 drug approved in the US following a nod from the FDA.

Views & Analysis

Data hackathon analyses truth behind ‘game-changer’ COVID vaccine

Data hackathon analyses truth behind TB vaccine and COVID-19

Is a century-old vaccine a ‘game-changer’ for COVID-19?

News

Roche to co-develop remdesivir rival in partnership with Ate...

Roche may not be the first company that comes to mind for a COVID-19 treatment, but the Swiss firm is taking a big swing at the market to rival Gilead’s

Convalescent plasma misses the mark in phase 2 trial

AZ, J&J COVID-19 vaccine trials okay to restart in US

Moderna nears COVID-19 vaccine finish line as it wraps up st...

Gilead’s remdesivir finally gets US approval

Data hackathon analyses truth behind TB vaccine and COVID-19

Roche to co-develop remdesivir rival in partnership with Ate...

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

COVID-19

Editor's Picks